1
|
Ando K, Heymann MF, Stresing V, Mori K,
Rédini F and Heymann D: Current therapeutic strategies and novel
approaches in osteosarcoma. Cancers (Basel). 5:591–616. 2013.
View Article : Google Scholar
|
2
|
Yang J and Zhang W: New molecular insights
into osteosarcoma targeted therapy. Curr Opin Oncol. 25:398–406.
2013. View Article : Google Scholar : PubMed/NCBI
|
3
|
Villani F, Galimberti M and Comazzi R:
Early cardiac toxicity of 4′-iodo-4′-deoxydoxorubicin. Eur J
Cancer. 27:1601–1604. 1991. View Article : Google Scholar
|
4
|
Dash R, Bhoopathi P, Das SK, Sarkar S,
Emdad L, Dasgupta S, Sarkar D and Fisher PB: Novel mechanism of
MDA-7/IL-24 cancer-specific apoptosis through SARI induction.
Cancer Res. 74:563–574. 2014. View Article : Google Scholar :
|
5
|
Luo J, Xia Q, Zhang R, Lv C, Zhang W, Wang
Y, Cui Q, Liu L, Cai R and Qian C: Treatment of cancer with a novel
dual-targeted conditionally replicative adenovirus armed with
mda-7/IL-24 gene. Clin Cancer Res. 14:2450–2457. 2008. View Article : Google Scholar : PubMed/NCBI
|
6
|
Zhu Y, Lv H, Xie Y, Sheng W, Xiang J and
Yang J: Enhanced tumor suppression by an ING4/IL-24 bicistronic
adenovirus-mediated gene cotransfer in human non-small cell lung
cancer cells. Cancer Gene Ther. 18:627–636. 2011. View Article : Google Scholar : PubMed/NCBI
|
7
|
Han Y, Miao J, Sheng W, Wang X, Jing Y,
Shan Y, Liu T, Bao W and Yang J: Interleukin 24 inhibits growth and
induces apoptosis of osteosarcoma cells MG-63 in vitro and in vivo.
Sheng Wu Gong Cheng Xue Bao. 25:1538–1545. 2009.In Chinese.
|
8
|
Pesonen S, Kangasniemi L and Hemminki A:
Oncolytic adenoviruses for the treatment of human cancer: Focus on
translational and clinical data. Mol Pharm. 8:12–28. 2011.
View Article : Google Scholar
|
9
|
Sun X, Geng X, Zhang J, Zhao H and Liu Y:
miR-155 promotes the growth of osteosarcoma in a HBP1-dependent
mechanism. Mol Cell Biochem. 403:139–147. 2015. View Article : Google Scholar : PubMed/NCBI
|
10
|
Ma L, Liu J, Liu L, Duan G, Wang Q, Xu Y,
Xia F, Shan J, Shen J, Yang Z, et al: Overexpression of the
transcription factor MEF2D in hepatocellular carcinoma sustains
malignant character by suppressing G2-M transition genes. Cancer
Res. 74:1452–1462. 2014. View Article : Google Scholar : PubMed/NCBI
|
11
|
Xu J, Mo Y, Wang X, Liu J, Zhang X, Wang
J, Hu L, Yang C, Chen L and Wang Y: Conditionally replicative
adenovirus-based mda-7/IL-24 expression enhances sensitivity of
colon cancer cells to 5-fluorouracil and doxorubicin. J
Gastroenterol. 48:203–213. 2013. View Article : Google Scholar
|
12
|
Zhao D, Yuan H, Yi F, Meng C and Zhu Q:
Autophagy prevents doxorubicin-induced apoptosis in osteosarcoma.
Mol Med Rep. 9:1975–1981. 2014.PubMed/NCBI
|
13
|
Whitaker EL, Filippov VA and
Duerksen-Hughes PJ: Interleukin 24: Mechanisms and therapeutic
potential of an anti-cancer gene. Cytokine Growth Factor Rev.
23:323–331. 2012. View Article : Google Scholar : PubMed/NCBI
|
14
|
Chan JR, Blumenschein W, Murphy E, Diveu
C, Wiekowski M, Abbondanzo S, Lucian L, Geissler R, Brodie S,
Kimball AB, et al: IL-23 stimulates epidermal hyperplasia via TNF
and IL-20R2-dependent mechanisms with implications for psoriasis
pathogenesis. J Exp Med. 203:2577–2587. 2006. View Article : Google Scholar : PubMed/NCBI
|
15
|
Liu XY and Gu JF: Targeting
gene-virotherapy of cancer. Cell Res. 16:25–30. 2006. View Article : Google Scholar : PubMed/NCBI
|
16
|
Emdad L, Lebedeva IV, Su ZZ, Sarkar D,
Dent P, Curiel DT and Fisher PB: Melanoma differentiation
associated gene-7/interleukin-24 reverses multidrug resistance in
human colorectal cancer cells. Mol Cancer Ther. 6:2985–2994. 2007.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Mao Z, Bian G, Sheng W, He S, Yang J and
Dong X: Adenovirus-mediated IL-24 expression enhances the
chemo-sensitivity of multidrug-resistant gastric cancer cells to
cisplatin. Oncol Rep. 30:2288–2296. 2013.PubMed/NCBI
|
18
|
Fang P, Zhang X, Gao Y, Ding CR, Cui F and
Jiao SC: Reversal effect of melanoma differentiation associated
gene-7/interleukin-24 on multidrug resistance in human
hepatocellular carcinoma cells. Anat Rec (Hoboken). 295:1639–1646.
2012. View
Article : Google Scholar
|
19
|
Yang C, Tong Y, Ni W, Liu J, Xu W, Li L,
Liu X, Meng H and Qian W: Inhibition of autophagy induced by
overexpression of mda-7/interleukin-24 strongly augments the
antileukemia activity in vitro and in vivo. Cancer Gene Ther.
17:109–119. 2010. View Article : Google Scholar
|
20
|
Bhutia SK, Dash R, Das SK, Azab B, Su ZZ,
Lee SG, Grant S, Yacoub A, Dent P, Curiel DT, et al: Mechanism of
autophagy to apoptosis switch triggered in prostate cancer cells by
antitumor cytokine melanoma differentiation-associated gene
7/interleukin-24. Cancer Res. 70:3667–3676. 2010. View Article : Google Scholar : PubMed/NCBI
|
21
|
Kumari S, Bonnet MC, Ulvmar MH, Wolk K,
Karagianni N, Witte E, Uthoff-Hachenberg C, Renauld JC, Kollias G,
Toftgard R, et al: Tumor necrosis factor receptor signaling in
keratinocytes triggers interleukin-24-dependent psoriasis-like skin
inflammation in mice. Immunity. 39:899–911. 2013. View Article : Google Scholar : PubMed/NCBI
|
22
|
Wang F, Smith N, Maier L, Xia W,
Hammerberg C, Chubb H, Chen C, Riblett M, Johnston A, Gudjonsson
JE, et al: Etanercept suppresses regenerative hyperplasia in
psoriasis by acutely downregulating epidermal expression of
interleukin (IL)-19, IL-20 and IL-24. Br J Dermatol. 167:92–102.
2012. View Article : Google Scholar : PubMed/NCBI
|
23
|
Liu J, Ma L, Li C, Zhang Z, Yang G and
Zhang W: Tumor-targeting TRAIL expression mediated by miRNA
response elements suppressed growth of uveal melanoma cells. Mol
Oncol. 7:1043–1055. 2013. View Article : Google Scholar : PubMed/NCBI
|